to Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the hinotori: Initial experience with two cases ORN with IVCTT is the golden standard treatment for RCC with IVC tumor thrombus. However, recent advances in minimally invasive robot-assisted surgery have enabled urologists to perform RARN with IVCTT. Recently, Garg et al. demonstrated in a systematic review and meta-analysis of perioperative outcomes that if well-experienced urologists perform RARN with IVCTT in carefully selected patients, favorable outcomes could be obtained. Particularly, RARN with IVCTT was associated with lower blood transfusion rate, fewer overall complications, and shorter hospital stays compared with ORN. 1 However, RARN with IVCTT remains challenging.Among new robotic systems, hinotori is a novel surgical robot developed in Japan by the Medicaroid Corporation (Kobe, Hyogo, Japan). Its features are designed to eliminate the need for port docking and minimize interference between arms, and it is equipped with eight axes of motion. Collectively, it has unique advantages that are different from existing platforms. 2 Presently, the authors reported the initial experience of RARN with IVCTT using hinotori for two cases with right RCC. 3 The levels of IVC tumor thrombus based on the classification were levels I and II. 4 The operations were successfully completed with a purely robotic procedure; no significant complications occurred and perioperative outcomes were satisfactory. Additionally, their perioperative outcomes with hinotori were comparable to those with da Vinci in their experienced cases.RARN with IVCTT should be carefully selected, especially in Japan, as these procedures have recently been introduced. However, it is of interest that RARN with IVCTT for cases with IVC tumor thrombus level < II using hinotori can achieve similar perioperative outcomes to an existing robotic system, such as da Vinci.Further studies are needed to assess the clinical efficacy of RARN with IVCTT using hinotori, especially for cases with IVC tumor thrombus level > III. However, this report has potential novelty, especially in Japan.